Vitls
Vitls is a Houston-based healthcare technology company developing an FDA 510(k)-cleared, continuous vital signs monitoring platform — the disposable Tégo wearable, Vitls Cloud, and Vitls App — that serves hospitals, pediatric patients, emergency departments, and clinical trial operators.
- Company typePrivate
- Founded2016
- HeadquartersHouston, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Vitls does
Vitls is a Houston-based healthcare technology company that develops an FDA 510(k)-cleared continuous vital signs monitoring platform for clinical and home use. Founded in 2016 by Werner Vorster after his son suffered from febrile seizures, the company relocated from South Africa to Texas to access the U.S. healthcare market and the Texas Medical Center innovation ecosystem. The platform combines a disposable, thin, flexible, waterproof wearable device (Tégo) with a 5-day battery life, a HIPAA-compliant cloud backend (Vitls Cloud), and mobile/web applications (Vitls App and Dashboard) that stream continuous vital signs — including body temperature, pulse rate, heart rate variability, respiration rate, SpO2, sleep, and movement/fall detection — to clinicians and EHR systems.
The company targets hospitals and healthcare systems (post-operative monitoring, general floor surveillance outside the ICU), emergency departments (rapid triage), pharmaceutical companies and CROs (remote monitoring of clinical trial participants), and pediatric patients aged two and older as a differentiated use case. Its go-to-market is direct enterprise field sales to hospitals, supplemented by channel signals through accelerator and competition programs (TMCx, Dreamit Ventures, KidsX, NCC-PDI). Pricing is quote-based and not publicly disclosed.
Vitls generates revenue through two streams: sales of disposable Tégo wearable devices (hardware) and subscription/usage-based access to the Vitls Cloud platform (recurring SaaS-style). Revenue and customer count are not disclosed; the company reports only five or more healthcare-provider pilots in Houston, Philadelphia, and New York, including an IRB-approved study with Texas Children's Hospital and a trial invitation at a 30-bed oncology unit. The company has raised approximately $100K in angel funding (May 2017) plus roughly $85K in non-dilutive competition prize money, has 1–10 employees, and relies on a credentialed strategic and scientific advisory bench (former Welch Allyn CEO, former VitalConnect VP, Texas Children's Hospital CMO) to compensate for its small core team.
Vitls firmographics
Firmographics- Name
- Vitls
- Legal name
- Vitls Inc.
- Website
- https://vitlsinc.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Vitls is a Houston-based healthcare technology company developing an FDA 510(k)-cleared, continuous vital signs monitoring platform — the disposable Tégo wearable, Vitls Cloud, and Vitls App — that serves hospitals, pediatric patients, emergency departments, and clinical trial operators.
- Ownership category
- akta.pro rank
Vitls industry classification
Industry- Product category
- Remote Patient Monitoring
- NAICS
- Ambulatory Health Care Services (621)
- SIC
- Services-Home Health Care Services (8082)
- akta.pro primary industry
- Vital Signs Monitoring (Multi-parameter, Spot-Check & Continuous) (HLAHACAA)
- akta.pro secondary industry
- Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI)
Keywords
Where Vitls is headquartered
LocationHeadquarters
- HQ city
- Houston
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Vitls business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure, Operations
Revenue model
- Wearable Device Sales: Sale of disposable Tégo wearable devices to healthcare providers for continuous patient monitoring in hospital and home settings.
- Cloud/SaaS Platform: Subscription or usage-based access to Vitls Cloud platform for data storage, analytics, and integration with EHR systems and connected devices.
Go-to-market motion2 records
Distribution channels1 record
Marketing channels5 records
Vitls product offering
Product offeringCore offering
Vitls develops a clinical-grade continuous vital signs monitoring platform consisting of the Tégo disposable wearable device, Vitls Cloud data infrastructure, and Vitls App/Dashboard. The platform enables hospitals and healthcare providers to continuously monitor patient vital signs including body temperature, pulse rate, heart rate variability, respiration rate, SpO2, sleep, and movement for up to 5-6 days. It integrates with hospital EHR systems and delivers real-time notifications when patient vitals deteriorate.
Product overview
Vitls offers a unified remote patient monitoring platform consisting of three integrated components: the Tégo wearable device (a small, disposable, wireless vital signs monitor worn on the chest), the Vitls Cloud (HIPAA-compliant cloud database for data storage and transmission), and the Vitls App/Dashboard (for viewing continuous vital sign data, receiving instant notifications, and accessing patient trends). The platform is designed for continuous, unobtrusive monitoring of patients in hospital and home settings, enabling early detection of patient deterioration.
Differentiator
Problem solved
Functional benefit
Brands
- Tégo: The company's flagship wearable medical device for continuous vital sign monitoring, including body temperature, pulse rate, heart rate variability, respiration rate, SpO2, sleep, and movement tracking.
- Vitls Platform
Products and services
- Vitls Platform Clinical-grade remote patient monitoring platform combining the Tégo wearable device, Vitls Cloud, and Vitls App for continuous vital sign data capture, storage, transmission, and review. Designed for hospital and home use.
- Tégo Wearable Device Small, thin, flexible, waterproof, disposable wireless wearable medical device placed on the patient that continuously monitors body temperature, pulse rate, heart rate variability, respiration rate, pulse ox (SpO2), sleep, and movement for up to 5-6 days on a single battery.
- Vitls Cloud HIPAA-compliant cloud database that ingests vital sign data from Tégo devices and transmits it to EHR systems, nurse stations, the Vitls App, and connected smart devices with real-time notifications and trend history.
- Vitls App Native iOS and Android mobile application that displays continuous vital sign data, delivers instant notifications, shows complete patient data trends, and allows providers to add notes.
- Vitls Dashboard Web-based dashboard accessible via any browser providing live monitoring view, instant notifications, patient data trends, and the ability to add notes; intended for nurse stations and clinical workstations.
Quantifiable outcome
- Deterioration can be identified and treated more than 60 percent earlier with continuous, remote monitoring
- +2 more outcomes
Companies that use Vitls
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles3 records
Vitls technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
Feature5 records
Vitls partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core.
- KidsX AcceleratorcoreAccepted into KidsX, the largest pediatric-focused digital health accelerator globally. The 13-week virtual program pairs early-stage digital health companies with clinician and administrative leaders at leading pediatric hospitals to validate clinical efficacy and scale solutions.
- Texas Medical Center Innovation Institute (TMCx)coreParticipated in TMCx Medical Device Program in 2017. The program provides startups access to hospital stakeholders and key opinion leaders at the world's largest medical center.
- Dreamit VenturescoreAccepted into Dreamit Ventures' Health Program in Philadelphia. The program provides access to Dreamit's network and expertise in health technology commercialization.
- National Capital Consortium for Pediatric Device Innovation (NCC-PDI)coreWon $50,000 grant at NCC-PDI 'Make Your Medical Device Pitch for Kids!' COVID-19 edition competition. NCC-PDI is one of five members in FDA's Pediatric Device Consortia Grant Program.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
Vitls competitors and assessment
Company assessmentBroad incumbents
- Masimo: Masimo is a global leader in pulse oximetry and patient monitoring with wearable products (e.g., Radius PPG, MightySat) and a connected health platform, representing a broad incumbent competing across multiple vital signs categories Vitls addresses.
- GE HealthCare: GE HealthCare provides a broad portfolio of patient monitoring solutions (including wearable and continuous monitoring within its CARESCAPE and Mural offerings), positioning it as a larger incumbent that hospitals may choose over point solutions like Vitls.
- Philips (BioTelemetry / RPM): Philips acquired BioTelemetry to expand its remote cardiac and multi-parameter monitoring portfolio, making it a broad incumbent offering hospital and home RPM solutions that overlap with Vitls' continuous monitoring use cases.
Direct peers
- iRhythm Technologies: iRhythm's Zio wearable cardiac monitor provides continuous ambulatory ECG monitoring with cloud-based analytics, offering a comparable model of disposable wearable plus cloud platform for remote patient monitoring.
- VitalConnect: VitalConnect offers the VitalPatch, a wearable biosensor for continuous multi-parameter vital sign monitoring in hospital and remote settings, directly competing with the Vitls T égo device in clinical-grade continuous monitoring use cases.
- Preventice Solutions (Boston Scientific): Preventice offers BodyGuardian wearable remote cardiac monitors used in hospital-to-home transitions, a comparable model of wearable biosensor plus cloud monitoring that now competes under Boston Scientific's commercial reach.
- Sotera Wireless: Sotera Wireless developed the ViSi Mobile wearable monitor for continuous surveillance of multiple vital signs in ambulatory hospital patients, making it a directly comparable peer in continuous wearable vital signs monitoring.
- EarlySense: EarlySense provides contact-free continuous monitoring of heart rate, respiration, and motion for hospital and post-acute settings, competing for the same clinical use cases of detecting patient deterioration outside the ICU.
Emerging players
- Empatica: Empatica develops FDA-cleared wearable devices and a cloud platform for continuous health monitoring (including pediatric epilepsy detection), overlapping with Vitls on wearable form factor, clinical-grade monitoring, and pediatric use cases.
- Medidata Solutions (Dassault Systèmes): Medidata offers decentralized clinical trial platforms with wearable sensor integrations for remote patient monitoring during trials, directly comparable to Vitls' pharmaceutical/CRO use case for monitoring trial participants at home.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
Vitls social profiles
Digital presenceVitls compliance and trust
Trust signalCompliance2 records
Vitls financial estimates
Financial estimateRevenue estimate
Valuation estimate
Vitls leadership team
Management profileNumber of profiles
Profiles9 records
Vitls funding detail
Funding detailFunding overview
Funding rounds4 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Vitls M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Vitls
What does Vitls do?
Vitls develops a clinical-grade continuous vital signs monitoring platform consisting of the Tégo disposable wearable device, Vitls Cloud data infrastructure, and Vitls App/Dashboard. The platform enables hospitals and healthcare providers to continuously monitor patient vital signs including body temperature, pulse rate, heart rate variability, respiration rate, SpO2, sleep, and movement for up to 5-6 days. It integrates with hospital EHR systems and delivers real-time notifications when patient vitals deteriorate.
Is Vitls a public or private company?
Vitls is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Vitls founded?
Vitls was founded in 2016. It employs 1 to 10 people.
Where is Vitls based?
Vitls is headquartered in Houston, United States, in the North America region.
How does Vitls make money?
Two revenue lines are on record. Wearable Device Sales are the primary driver. The others are cloud/SaaS Platform.
Who are Vitls's main competitors?
Broad incumbents on record are Masimo, GE HealthCare and Philips (BioTelemetry / RPM). Direct peers are iRhythm Technologies, VitalConnect, Preventice Solutions (Boston Scientific), Sotera Wireless and EarlySense. Emerging players are Empatica and Medidata Solutions (Dassault Systèmes).
Does Vitls have an API?
No public API is recorded for Vitls.
What industry is Vitls in?
Vitls's product category is Remote Patient Monitoring. Its primary akta.pro industry code is HLAHACAA, Vital Signs Monitoring (Multi-parameter, Spot-Check & Continuous), with a secondary code of HLACAPAI, Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration). Its NAICS code is 621 and its SIC code is 8082.